… Study Rationale: To evaluate treatments in ways that are meaningful to people … disease (PD), we need to identify measurements that reflect how people with early PD function and feel. The Critical … in early PD trials. The staff at C-Path include clinical outcome assessment experts who have extensive experience in …

… aggregation of a protein known as alpha-synuclein appears to play a critical role in Parkinson's disease. This project … preliminary tests are promising, future work could explore how this aptamer could be used as a disease-modifying … slow or halt disease progression.   Anticipated Outcome:           This project represents an important first …

… Photo by Scott Henrichsen Update as of September 17, 2024: Join … Council , MJFF has responded to the EPA's latest public comment opportunity urging them to ban paraquat. Read the comment . Update as of January 31, 2024: The EPA has opened …

… with Parkinson’s disease (PD). With some early prototypes, we have helped a small number of people with PD … to wear such a device every day, it also needs to be light, comfortable, stylish and easy to use. Our goal is to build a … enough to be given to users for longer-term unsupervised testing. We will then do a larger, randomized controlled …